BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12094400)

  • 1. [Is research in Germany up for sale? Results of a study of Transparency International Germany].
    Bojunga G
    Wien Med Wochenschr; 2002; 152(9-10):244-5. PubMed ID: 12094400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consequences of the German anticorruption law for sponsorship at university hospitals].
    Neubauer A
    Wien Med Wochenschr; 2002; 152(9-10):246-8. PubMed ID: 12094401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physicians--victims or promoters of corruption?].
    Kind M
    Wien Med Wochenschr; 2002; 152(9-10):249-52. PubMed ID: 12094402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Science between sponsorship and corruption"].
    Beyer J; Frewer A; Kingreen D; Meran JG
    Wien Med Wochenschr; 2002; 152(9-10):233. PubMed ID: 12094396
    [No Abstract]   [Full Text] [Related]  

  • 5. [Scientific graduate education, sponsorship and research cooperation in the anti-corruption law tension field--effects on members of the German Society of Rheumatology].
    Burmester GR
    Z Rheumatol; 2000 Jun; 59(3):162-71. PubMed ID: 10929444
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical research and industrial sponsoring: avenues towards transparency and credibility.
    Hildebrandt M; Ludwig WD
    Onkologie; 2003 Dec; 26(6):529-34. PubMed ID: 14709925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Illegal professional conflict of interest from the viewpoint of university research].
    Dietel M
    Z Arztl Fortbild Qualitatssich; 1998 Oct; 92(8-9):620-5. PubMed ID: 9885173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sponsorship of medical congresses, workshops and symposia by the pharmaceutical industry: as a physician, exercise caution!].
    Warntjen M
    Unfallchirurg; 2010 Feb; 113(2):159-63. PubMed ID: 20143201
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research support and the pharmaceutical industry in Germany].
    Hösch H
    Wien Med Wochenschr; 2002; 152(9-10):238-40. PubMed ID: 12094398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Criminal implication of sponsoring in medicine: legal ramifactions and recommendations].
    Mahnken AH; Theilmann M; Bolenz M; Günther RW
    Rofo; 2005 Aug; 177(8):1070-6. PubMed ID: 16021538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correspondence (letter to the editor): Search bias.
    Braschoss A
    Dtsch Arztebl Int; 2010 Sep; 107(38):671-2; author reply 673-4. PubMed ID: 20953260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aims and background of the anticorruption law].
    Mühlhausen H
    Wien Med Wochenschr; 2002; 152(9-10):241-3. PubMed ID: 12094399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does financing researchers and research at university clinics entail a conflict of interests and dependence?].
    Adler G
    Z Gastroenterol; 1999 Jul; Suppl 2():28-32. PubMed ID: 10472696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Are contacts with established radiologists punishable by law in the future?].
    Steinhäuser RT; Wigge P
    Rofo; 2011 Jan; 183(1):78-80. PubMed ID: 21229485
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sponsorship, conflict of interest and corruption: promoting science in discussion of medical ethics].
    Frewer A
    Wien Med Wochenschr; 2002; 152(9-10):234-7. PubMed ID: 12094397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [For and against: does sponsoring impede the growth of knowledge in medicine?].
    Finzen A; Fritze J
    Psychiatr Prax; 2007 May; 34(4):162-4. PubMed ID: 17520527
    [No Abstract]   [Full Text] [Related]  

  • 17. Correspondence (letter to the editor): National foundation.
    Freund M
    Dtsch Arztebl Int; 2010 Sep; 107(38):671; author reply 673-4. PubMed ID: 20953259
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of the "law for controlling corruption" on the relations been physicians and the health care industry].
    Heberer J
    Chirurg; 2000 Sep; 71(9):suppl 238-44. PubMed ID: 11043143
    [No Abstract]   [Full Text] [Related]  

  • 19. Open Payments Program (aka the Sunshine Act) makes public debut.
    Schmidt C
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214569
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
    James JS
    AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.